Follicum announced in February 2015 that they had finished two smaller toxicity studies with favorable results. The company has now started two larger toxicity studies which will finish in August 2015. These toxicity studies are necessary to get the authorities’ approval for clinical studies.
For more information please contact
Dr Jan Alenfall – CEO, Follicum AB
Tel: +46 46 19 21 97